Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

71 results about "Leucosis" patented technology

Leucosis is a leukemia-like malignant viral disease that is found in animals, particularly poultry and cattle.

Avian leukemia virus whole genome sequencing method based on nanopore sequencing

The invention provides an amplification primer and method for an avian leukosis virus whole genome. The detection primer group for the avian leukosis virus comprises 18 pairs of amplification primers, and the specific sequences of the amplification primers are as shown in SEQ ID NO.1-36. The detection primer group provided by the invention can realize relatively uniform coverage on the avian leukosis virus, and 100% region coverage of a genome is realized in nanopore sequencing. The preparation method of the sequencing fragment of the avian leukosis virus whole genome is simple, convenient and easy to operate, the amplification effect is good, nanopore sequencing has the advantage of simultaneous sequencing and real-time analysis, the detection time can be greatly shortened, infection of the avian leukosis virus can be rapidly identified and diagnosed, meanwhile, the whole genome sequence of the avian leukosis virus is obtained, and the application prospect is wide. The obtained genome sequence can provide a scientific basis for virus traceability, pathogenic variation tracking, novel strain identification, early warning and the like.
Owner:WENS FOODSTUFF GROUP CO LTD

Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus

The present disclosure belongs to the field of biotechnology, and specifically relates to a method for efficiently infecting human natural killer (NK) cells and other immune cells with a pseudovirus. Specifically, a viral transfection system provided in the present disclosure has an envelope plasmid with a protein having an X—Y—Z structure. The X is an extracellular (ex) structure of a gibbon ape leukemia virus (GALV) envelope glycoprotein, the Y is a transmembrane (TM) structure of the GALV envelope glycoprotein, and the Z is an intracellular segment portion of a murine virus gene.
Owner:BEIJING GENE MINK BIOTECHNOLOGY CO LTD

Antibody or antigen binding fragment specifically binding to avian leukosis virus p27 protein and application thereof

The invention relates to the technical field of antibodies, in particular to an antibody or an antigen binding fragment specifically binding to avian leukosis virus p27 protein and application of the antibody or the antigen binding fragment. The antibody or the antigen binding fragment contains a heavy chain variable region and a light chain variable region, the amino acid sequence of the heavy chain variable region is shown as SEQ.ID NO.1 or SEQ.ID NO.5, and the amino acid sequence of the light chain variable region is shown as SEQ.ID NO.3 or SEQ.ID NO.7. The antibody or the antigen binding fragment is positive in reaction with the avian leukosis virus, so that the antibody or the antigen binding fragment has good reaction characteristics with the avian leukosis virus.
Owner:LUOYANG PULIKE WANTAI BIOTECH

Reagent for detecting avian leukosis virus, nano-enzyme immunochromatography test strip and application of nano-enzyme immunochromatography test strip

ActiveCN120741854AImmunoglobulins against virusesBiological testingLeucosisAvian leukosis viruses
The invention provides a reagent for detecting avian leukosis virus, a nano-enzyme immunochromatography test strip and application of the nano-enzyme immunochromatography test strip, and belongs to the technical field of immunology. Aiming at the problems that the existing avian leukosis virus detection method is complicated in operation, time-consuming or strong in equipment dependence, the reagent comprises a capture antibody and a detection antibody; a heavy chain variable region of the monoclonal antibody A comprises an amino acid sequence as shown in SEQ ID NO: 1, and a light chain variable region of the monoclonal antibody A comprises an amino acid sequence as shown in SEQ ID NO: 2; a heavy chain variable region of the monoclonal antibody B comprises an amino acid sequence as shown in SEQ ID NO: 5, and a light chain variable region of the monoclonal antibody B comprises an amino acid sequence as shown in SEQ ID NO: 6; the antigen binding fragment is a Fab fragment, an F (ab) 2 fragment or a single-chain Fv fragment. The reagent is mainly used for detecting avian leukosis virus, and is suitable for detecting samples such as cloaca swab, meconium, egg white or serum of poultry.
Owner:INST OF URBAN AGRI CHINESE ACADEMY OF AGRI SCI +1

Avian leukosis virus whole genome sequencing method based on nanopore sequencing

The present invention provides primers and methods for amplifying the entire genome of avian leukosis virus. The detection primer set for avian leukosis virus includes 18 pairs of amplification primers, the specific sequences of which are shown in SEQ ID NOs. 1 to 36. The detection primer set provided by the present invention can achieve relatively uniform coverage of avian leukosis virus, and in nanopore sequencing, 100% regional coverage of the genome is achieved. The method for preparing sequencing fragments of the entire genome of avian leukosis virus provided by the present invention is simple and easy to operate, with good amplification effect. Nanopore sequencing has the advantage of real-time analysis while sequencing, which can greatly shorten the detection time and can quickly identify and diagnose avian leukosis virus infection. At the same time, its entire genome sequence can be obtained. The obtained genome sequence can provide a scientific basis for virus tracing, pathogen mutation tracking, new strain identification and early warning, etc.
Owner:WENS FOODSTUFF GROUP CO LTD

Method for rapidly obtaining chicken flocks capable of simultaneously resisting five kinds of subgroup avian leukosis and application of chicken flocks

The invention discloses a method for rapidly obtaining chicken flocks capable of simultaneously resisting five kinds of subgroup avian leukosis and application, and belongs to the technical field of poultry disease-resistant breeding. The method comprises the following steps: firstly, obtaining primordial germ cells of a donor chicken containing an anti-avian leukosis subgroup genotype I and an anti-avian leukosis subgroup genotype II through in-vitro separation and cultivation, then injecting the primordial germ cells of the chicken into chick embryo blood vessels of a receptor chicken with wild type tvas / s and tvbs / s genotypes, performing incubation and cultivation, performing genetic typing, and finally obtaining the chicken with the anti-avian leukosis subgroup genotype I and the anti-avian leukosis subgroup genotype II. And finally obtaining chicken flocks capable of simultaneously resisting five kinds of subgroup avian leukosis. The method optimizes a chicken primordial reproduction in-vitro efficient culture system, can quickly obtain different chicken flocks capable of simultaneously resisting five kinds of avian leukosis subgroups, can be applied to utilization and preservation of resistance germplasm resources of excellent chicken breeds in China, can be applied to breeding of disease-resistant chickens of different breeds, greatly shortens the period of traditional poultry anti-avian leukosis breeding, and has a wide application prospect. The novel technology has good application value and popularization prospect.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Recombinant retroviral vectors for gene therapy

The present invention relates to Split-Intron Final Self-Inactivating (SIN) retroviral vectors which comprises a viral major splice donor (mSD) comprising mutations, a mouse mammary tumor vector long terminal repeat (MMTV-LTR) or a Type B leukemogenic virus long terminal repeat (TBLV-LTR), a eukaryotic splice acceptor (eSA), and a eukaryotic splice donor (eSD). Furthermore, the invention relation to the use and methods of uses of such vectors in gene therapy.
Owner:UNITED ARAB EMIRATES UNIVERSITY

A cell-ELISA kit for detecting chicken astrovirus type Ⅱ antibody and a preparation method thereof

The application belongs to the technical field of biology and particularly relates to an ELISA kit for detecting chicken astrovirus type II antibodies and a preparation method. The Cell-ELISA experiment is carried out by using LMH cells infected with chicken astrovirus type II to detect the chicken astrovirus type II antibodies. The method has no cross reactivity with positive serum of Newcastle disease virus, avian influenza virus, chicken infectious anemia virus, avian leukosis virus, Marek's virus and chicken infectious bursal virus, which indicates that the method has good specificity. The Cell-ELISA method is used to detect the chicken serum sample to be detected by using whole virus infection, and is assembled into a kit for measuring chicken astrovirus antibodies in serum. The kit can be used for serological diagnosis of chicken astrovirus type II infection, monitoring of the level of antibodies, epidemiological investigation and the like, and provides a novel and effective detection means for prevention and treatment of chicken astrovirus type II.
Owner:YANGZHOU UNIV

Traditional Chinese medicine composition for enhancing immunity and treating chicken virus infection and preparation method thereof

The invention belongs to the field of veterinary traditional Chinese medicines, and provides a traditional Chinese medicine composition for enhancing immunity and treating chicken virus infection and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 18 to 22 parts of radix isatidis, 18 to 22 parts of indigo naturalis, 15 to 20 parts of radix angelicae sinensis, 10 to 15 parts of poria cocos, 10 to 15 parts of rhizoma alismatis, 8 to 12 parts of medicated leaven, 8 to 12 parts of radix salviae miltiorrhizae, 8 to 12 parts of radix codonopsis, 8 to 12 parts of rhizoma cyperi and 4 to 8 parts of liquorice root. The traditional Chinese medicine composition disclosed by the invention has outstanding performance in the aspect of improving IgG and IgM levels, and further shows that the traditional Chinese medicine composition disclosed by the invention can effectively stimulate immune response of an organism and enhance the resistance of the organism to viruses. Animal pharmacological experiments show that the compound has a remarkable treatment effect on chicken infectious disease anemia, avian leukosis and chicken adenovirus infection, provides a new treatment thought for treatment of chicken viral infection, and has a wide application prospect.
Owner:SHANDONG VOCATIONAL ANIMAL SCI & VETERINARY COLLEGE

Application of LOXL2 gene in resisting avian leukosis virus infection

The invention discloses application of a LOXL2 gene in resisting avian leukosis virus infection, and belongs to the technical field of biology. The nucleotide sequence of the LOXL2 gene is as shown in SEQ ID NO. 1. The invention provides a new gene target LOXL2 related to avian leukosis virus infection resistance, and proves the effect of the LOXL2 gene in regulating and controlling avian leukosis virus replication. Replication of the avian leukemia virus can be promoted by inhibiting expression of the LOXL2 gene in a host cell, and replication of the avian leukemia virus can be inhibited by overexpressing the LOXL2 gene in the host cell. According to the invention, favorable theoretical guidance and technical support are provided for the application of the LOXL2 gene as a target in the aspects of development of drugs for treating avian leukemia, breeding of transgenic animals for resisting avian leukemia, construction of avian leukemia virus infection models and the like, and the LOXL2 gene has wide application prospects and extremely high market value.
Owner:YAZHOUWAN NATIONAL LABORATORY +2

Method for rapidly identifying avian leukosis virus

The invention relates to the field of avian virus detection, and discloses a method for rapidly identifying avian leukosis virus, which comprises the following steps: S1, sample collection and pretreatment: firstly collecting a poultry sample, S2, loading a micro-fluidic chip, and then injecting the pretreated sample into the micro-fluidic chip; s3, performing micro-fluidic LAMP amplification on the micro-fluidic chip to obtain enough products for subsequent detection; s4, a CRI SPR specific detection amplification product automatically enters a CRI SPR reaction chamber in the chip; and S5, collecting and analyzing a detection signal, and reading a fluorescence signal on the chip by using a portable fluorescence detector. By fusing the rapid amplification capability of the microfluidic LAMP and the high-specificity detection advantage of CRISPR / Cas12a, the avian leukosis virus can be rapidly, sensitively and specifically recognized, the portable and field application is realized, the target sequence in the amplification product is recognized, the cleavage function is activated, and the detection sensitivity is high. In use, whether a sample reacted by a fluorescence signal contains viruses or not can be quickly identified.
Owner:ANHUI CHENGXI AGRI TECH CO LTD

Primer probe combination for identifying E, J and K subgroups of avian leukosis virus, detection method and application of primer probe combination

The invention relates to a primer probe combination for identifying E, J and K subgroups of avian leukosis viruses, a detection method and application of the primer probe combination. The detection system for identifying the avian leukosis virus subgroup comprises an upstream primer ALV-E-F, a downstream primer ALV-E-R and a probe ALV-E-P of a gp85 gene conserved region of targeted ALV-E, and an upstream primer ALV-J-F, a downstream primer ALV-J-R and a probe ALV-J-P of an env gene conserved region of targeted ALV-J, the upstream primer ALV-K-F, the downstream primer ALV-K-R and the probe ALV-K-P are used for targeting a gp85 gene conserved region of ALV-K. The detection system for identifying the avian leukosis virus subgroups has no cross reaction with other ALV subgroups and common avian pathogens, and has strong specificity.
Owner:FOSHAN UNIVERSITY +1

Method and kit for simultaneously detecting avian leukosis virus, mycoplasma synoviae and salmonella pullorum antibodies

The invention discloses a method and a kit for simultaneously detecting avian leukosis virus, mycoplasma synoviae and salmonella pullorum antibodies, and belongs to the technical field of animal epidemic disease detection. According to the method, an avian leukosis virus p27 protein, a chicken mycoplasma synoviae p50 protein and a truncated GroEL-delta8-1 protein of a dominant antigen GroEL of salmonella pullorum are taken as coating antigens, synchronous detection of the three antibodies is realized by optimizing ELSA reaction conditions, and a kit capable of simultaneously detecting the three antibodies is developed at the same time. The kit has the characteristics of strong specificity, high sensitivity and simplicity and convenience in operation, is suitable for rapid screening and purification of poultry epidemic diseases, and reduces the detection cost.
Owner:CHINA AGRI UNIV

A composition, method and use for increasing the titre of mouse leukemia virus

ActiveCN122104610BLeucosisTiter
The application provides a composition, a method and an application for improving the titer of mouse leukemia virus, and belongs to the technical field of biotechnology.The method comprises the following steps: before a host cell is infected with xenotropic mouse leukemia virus, the host cell is pretreated by using SC79; during virus infection of the pretreated host cell and during cell passage, mifepristone is added to a culture medium; and during continuous virus harvesting, LR3 IGF-1 is added to the culture medium.Through adding additives with different functional mechanisms at different stages of virus production, the application realizes dynamic optimization of the whole process of virus production.The experimental results show that the combination of SC79, mifepristone and LR3 IGF-1 can increase the titer of xenotropic mouse leukemia virus by 14.32 times, which is significantly better than the effect of single additive or two additives in combination.The application solves the problems of low titer of virus stock solution and low production efficiency in the prior art.
Owner:SINO BIOLOGICAL INC

Separation agent for RNA with 5' cap structure

To provide a separation agent for RNA with a 5' cap structure or the like, enabling the efficient and economical separation of RNA with a 5' cap structure.SOLUTION: The present invention provides a separation agent for RNA with a 5' cap structure or the like in which the terminal unit is a 7-methylguanylic acid residue, where the agent comprises a compound represented by formula (I): A-L-R1 (I) (where A represents a separation carrier residue with a reactive functional group, L represents a linker, and R1 represents a group that reacts with the 7-methylguanine moiety of 7-methylguanosine to form a protecting group).SELECTED DRAWING: None
Owner:NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE & TECHNOLOGY

Use of LOXL2 gene in resisting avian leukosis virus infection

The application discloses application of a LOXL2 gene in resisting avian leukemia virus infection and belongs to the technical field of biotechnology.The nucleotide sequence of the LOXL2 gene is shown as SEQ ID NO.1.The application provides a new gene target point LOXL2 related to resisting avian leukemia virus infection, and proves the role of the LOXL2 gene in regulating avian leukemia virus replication.Inhibition of LOXL2 gene expression in host cells can promote avian leukemia virus replication, and overexpression of the LOXL2 gene in host cells can inhibit avian leukemia virus replication.The application provides favorable theoretical guidance and technical support for application of the LOXL2 gene as a target point in developing drugs for treating avian leukemia, breeding transgenic animals resisting avian leukemia, and constructing an avian leukemia virus infection model, and has a wide application prospect and extremely high market value.
Owner:YAZHOUWAN NATIONAL LABORATORY +2

Avian leukosis antigen detection kit and preparation method thereof

ActiveCN120214310BImmunoglobulins against virusesImmunoassaysLeucosisAvian leukosis viruses
The present invention discloses an avian leukosis antigen detection kit and a preparation method thereof. The kit comprises an anti-avian leukosis virus P27 protein monoclonal antibody and a horseradish peroxidase-labeled sheep anti-P27 polyclonal antibody as a sandwich secondary antibody. The kit is based on a double-antibody sandwich method and has good specificity for A / B, J, and K subtype avian leukosis viruses prevalent in breeder chickens. The minimum detection limit is 1 ng / mL, the kit has strong anti-interference ability, a low false positive rate, and is easy to operate and highly stable. It is suitable for scenarios such as breeder chicken flock purification, SPF embryo quality monitoring, and epidemiological surveys. It effectively solves the problem of expensive imported products and limited domestic promotion, and has significant economic and social benefits.
Owner:GUANGDONG BIAOYUN BIOTECHNOLOGY CO LTD

High-affinity rabbit single-chain recombinant antibody, its application and the resulting reagent kit

This invention provides a high-affinity rabbit single-chain recombinant antibody, its application, and the resulting reagent kit, belonging to the field of immunology. The high-affinity rabbit single-chain recombinant antibody provided by this invention has the amino acid sequence shown in SEQ ID NO.1, named 111-scFv-Fc; and has the amino acid sequence shown in SEQ ID NO.5, named 86-scFv-Fc. The antibodies provided by this invention can recognize different antigenic determinants on the surface of avian leukosis virus (ALV). When applied to the detection of trace amounts of ALV, they exhibit advantages such as high specificity, high sensitivity, and good stability. The combination of the two single-chain recombinant antibodies shows high efficiency in ALV antigen detection, meeting the requirements for ALV detection in clinical samples, and has significant implications for clinical diagnosis and research applications.
Owner:SHENZHEN HERZ LIFE SCI TECH CO LTD

Molecular diagnosis method for avian leukosis virus and Marek's disease virus mixed infection

The invention provides a molecular diagnosis method for avian leukosis virus and Marek's disease virus mixed infection. The molecular diagnosis method comprises the following steps: (S01) collecting diseased material tissues; (S02) carrying out nucleic acid extraction on the sick material tissue of the sick chicken; (S03) detecting the nucleic acid by using specific primers of avian leukosis and Marek's disease; (S04) preparing a PCR (Polymerase Chain Reaction) detection system, and respectively adding ALV-env gene amplification primers and MDV-meq gene amplification primers for gene amplification; (S05) carrying out 1% agarose gel electrophoresis detection on the amplification product in the step (4), and carrying out sequence determination after determining a target band; (S06) carrying out BLAST comparison on the sequences obtained by sequencing, carrying out gene sequence analysis and drawing an evolutionary tree; and (S07) determining the virus type according to the homology and the evolutionary branches, so as to realize rapid diagnosis of ALV and MDV mixed infection, strain characteristic analysis and exclusion of other similar epidemic diseases, and provide technical support for accurate prevention and control of AL and MD in the poultry industry, provenance purification and epidemiological investigation.
Owner:长沙市动物疫病预防控制中心

TaqMan fluorescent quantitative primer combination for detecting AJ / BK subtype avian leukosis virus as well as application and kit of TaqMan fluorescent quantitative primer combination

The invention relates to the technical field of avian virus detection, in particular to a TaqMan fluorescent quantitative primer combination for detecting AJ / BK subtype avian leukosis virus as well as application and a kit of the TaqMan fluorescent quantitative primer combination. The TaqMan fluorescent quantitative primer combination for detecting the AJ / BK subtype avian leukosis virus comprises an AJ primer and a probe as well as a BK primer and a probe, and the sequences are shown as SEQ ID No.1-6. The RNA is directly detected by a one-step method, so that the detection speed is increased. According to the invention, only two fluorescence channels are used to increase sensitivity and convenience, the kit can distinguish endogenous and exogenous viruses, avoids endogenous viruses, and only can detect AJ / BK subtype avian leukosis viruses.
Owner:HEBEI UNIV OF ENG +1

Kit (virus antigen detection)

ActiveCN309707975SLeucosisAvian leukosis viruses
1. The name of the design product: kit (virus antigen detection). 2. The use of the design product: for containing each component of the kit for detecting avian leukosis virus. 3. The design points of the design product: the combination of shape, pattern and color. 4. The picture or photo that best shows the design points: perspective view 1. 5. The design for which protection is sought contains color.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

KIT FOR RAPID DETECTION OF AVIAN LEUKOSIS VIRUS SUBGROUP J BASED ON CRISPR / Cas13a SYSTEM

Provided is a kit for rapid detection of avian leukosis virus subgroup J (ALV-J) based on a CRISPR / Cas13a system. The method is based on the combination of the CRISPR / Cas13a system and recombinase aided amplification (RAA) for ALV-J detection. An oligonucleotide probe is designed as a substrate for CRISPR / Cas13a trans-cleavage and produces a detectable signal. The method can substantially improve detection sensitivity by amplifying a detection signal twice by RAA and T7 transcription. The detection method further exhibits excellent specificity, allowing for clear differentiate from other avian viruses. It does not require expensive experimental equipment and special laboratory environment, and it is rapid and efficient. The method is of great significance for biological research and on-site detection of ALV-J.
Owner:SOUTHWEST UNIV +1

Avian leukosis virus poly-subtype antigen epitope fusion protein and application thereof

ActiveCN116396400BLeucosisAvian leukosis viruses
The application provides an avian leukosis virus multi-subtype antigen epitope fusion protein, a multi-subtype recognition antibody, a detection kit and application thereof. The amino acid sequence of the avian leukosis virus multi-subtype antigen epitope fusion protein is shown as SEQ ID NO:1. Experiments show that the avian leukosis virus multi-subtype antigen epitope fusion protein is reactive to avian leukosis virus multi-subtype serum and is not reactive to other common chicken infectious virus or bacterial serum. The avian leukosis virus multi-subtype antigen epitope fusion protein can be used for preparing multi-subtype recognition antibodies by immunizing animals. The multi-subtype recognition antibody can be specifically recognized with multi-subgroup avian leukosis specific antigen epitopes, a detection kit is developed, and the detection kit is used for rapid screening and purification of chicken population avian leukosis virus, and has a good application prospect.
Owner:GUIZHOU BREEDING LIVESTOCK & POULTRY GERMPLASM TESTING CENT

Materials and methods for treating EIF2B5 mutations and diseases resulting therefrom

Gene therapy vectors, such as adeno-associated viruses (AAVs), designed for the treatment of mutations in the eukaryotic translation initiation factor 2B subunit epsilon (EIF2B5) gene are provided. The EIF2B5 gene provides instructions for making one of the five subunits of the eIF2B protein, specifically the epsilon subunit of the protein. Such mutations are associated with diseases or disorders such as leukoencephalopathy, macrocephalic leukoencephalopathy, leukodystrophy, stroke, migraine, epilepsy, multiple sclerosis (MS), Parkinson's disease (PD), Alzheimer's disease (AD), astrogliosis in aging, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), Alexander disease, hepatic encephalopathy (HE), Aicardi-Goutières syndrome, CLC-2-associated disease, oculodentodigital dysplasia, and / or giant axonal neuropathy. Such leukoencephalopathy or leukodystrophies include, but are not limited to, vanishing white matter (VWM). The disclosed gene therapy vector provides EIF2B5 cDNA to a subject in need, which results in the expression of wild-type or functional EIF2B5 protein. Also provided is a new promoter, designated gfa1405, designed to target astrocytes and neurons. Thus, compositions, nanoparticles, extracellular vesicles, exosomes, or vectors comprising the gfa1405 promoter, and methods of use thereof are also provided.
Owner:RES INST AT NATIONWIDE CHILDRENS HOSPITAL +1

Method for promoting avian leukosis virus proliferation

PendingCN120424886AMicroorganism based processesViruses/bacteriophagesLeucosisAvian leukosis viruses
The invention relates to the technical field of virus isolated culture, in particular to a method for promoting avian leukosis virus proliferation. The invention provides a method for promoting proliferation of avian leukosis viruses. The method comprises the step of culturing the avian leukosis viruses by taking STAT1 gene inactivated chicken DF-1 cells as host cells. The DF-1 cell strain with the STAT1 knocked out is established, when the cell strain is used for isolated culture of ALV, the proliferation rate of the ALV can be effectively increased, compared with an original DF-1 cell, the proliferation process of the virus can be remarkably accelerated, and the proliferation time is shortened from at least 7 days to 4 days. The DF-1 cell strain of which the STAT1 is knocked out can be used as a host cell to be applied to separation, amplification or detection of ALV in the industry, and shows an ideal amplification effect for poultry plasma samples under different health conditions.
Owner:GUANGXI UNIV +1

SiRNA for inhibiting chicken RASGRP3 gene expression and application thereof

The invention discloses siRNA (small interfering Ribonucleic Acid) for inhibiting the expression of a chicken RASGRP3 (Reduced Amplification of Sequence Growth Protein 3) gene and application of the siRNA, the siRNA comprises a positive-sense strand and an antisense strand, and is any one of RASGRP3-Anas-214, RASGRP3-Anas-846 and RASGRP3-Anas-1187. According to the specific siRNA aiming at the chicken RASGRP3 mRNA provided by the invention, in a chicken liver cancer cell line (LMH), after liposome-mediated transfection culture is performed for 48 hours, RT-qPCR is adopted to evaluate the transcript level, and a result shows that the relative expression quantity of the chicken RASGRP3 mRNA is remarkably reduced compared with that of negative control, and the repeatability is good. The polypeptide can be further used for inhibiting ALV-J replication, provides a new molecular intervention target for prevention and control of avian leukosis, and has important scientific research and potential economic values.
Owner:YANGZHOU UNIV

Molecular markers, screening / identification methods and their applications for genetic resistance to subgroup B avian leukosis virus infection in chickens

The present invention discloses a molecular marker, screening / identification method and application of chicken genetic resistance to subgroup B avian leukosis virus infection, the method comprising: extracting genomic DNA of a sample to be tested, amplifying a TVB receptor gene fragment, and then sequencing to determine whether there is a deletion of base G at position 3747 of the TVB receptor gene. The method can quickly and accurately determine whether the test sample is an ALV-B resistant chicken or a susceptible chicken, and can screen breeding materials for breeding chicken varieties / lines resistant to ALV-B infection from Chinese chicken breeds (including local chicken breeds and commercial broiler strains), providing technical support for breeding chicken varieties / lines resistant to ALV-B infection.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY +1

Avian leukemia virus detection kit based on magnetic particle chemiluminescence method and application thereof

PendingCN119667151ASuitable for purification monitoringeasy to operateChemiluminescene/bioluminescenceAntigenLeucosis
The invention belongs to the technical field of biological detection, and discloses an avian leukosis virus detection kit based on a magnetic particle chemiluminescence method and application thereof. The kit comprises a liquid A, a liquid B, a liquid C, a liquid D calibration product and a quality control product, the liquid A comprises magnetic particles coated with an avian leukosis virus antibody, and the liquid B comprises an acridinium ester labeled avian leukosis virus antibody. According to the kit disclosed by the invention, the avian leukosis virus antibody is coated on the magnetic particles, and the magnetic particles have a relatively large surface area, so that the antigen capture efficiency is greatly improved, and the detection specificity and sensitivity are enhanced. In addition, acridinium ester is adopted for labeling, the cost is low, enzyme catalysis is not needed, the influence of environment temperature and humidity on the reaction is small, luminescence is stable, the luminescence efficiency is high, background luminescence is low, the signal-to-noise ratio is high, the detection time is short, the detection efficiency and stability are greatly improved, and rapid detection of large-scale samples in production is facilitated.
Owner:深圳市绿诗源生物技术有限公司

Reagent for detecting avian leukemia virus and nanozyme immunochromatography test strip and application thereof

The application provides a reagent for detecting avian leukemia virus, a nanozyme immunochromatography test strip and application thereof, and belongs to the technical field of immunology. In view of the problems of complicated operation, time consumption and strong equipment dependence of the existing avian leukemia virus detection method, the reagent comprises a capture antibody and a detection antibody; the heavy chain variable region of a monoclonal antibody A comprises an amino acid sequence as shown in (SEQ ID NO: 1), and the light chain variable region comprises an amino acid sequence as shown in (SEQ ID NO: 2); the heavy chain variable region of a monoclonal antibody B comprises an amino acid sequence as shown in (SEQ ID NO: 5), and the light chain variable region comprises an amino acid sequence as shown in (SEQ ID NO: 6); and the antigen binding fragment is a Fab fragment, a F(ab)2 fragment or a single-chain Fv fragment. The reagent is mainly used for detecting avian leukemia virus and is suitable for detecting samples such as avian cloaca swabs, fetal meconium, egg white or serum.
Owner:INST OF URBAN AGRI CHINESE ACADEMY OF AGRI SCI +1